Questions
Ttnp
My portfolio consists of:
TBT (a bet that interest rates go higher)
UDN (a bet that the printing presses on overdrive will tank the $)
GDX, UGL (a bet against the $ is a bet on higher gold prices)
Recently I added a huge position in TTNP.
They recently got FDA approval for Fanapt in a $25B market space.
Sales projections are for between $1B and $5B of sales.
TTNP's 10% royalty translates to between $2 to $8 of earnings per share.
It seems to greatly undervalued in comparison to other biotechs.
DNDN has nothing approved and sports a $5B market cap.
CTIC has nothing approved, and may never get an approved drug, sells for $1B.
TTNP's market cap is only $70M.
They also have Probuphine which was successful in Phase 3.
Is TTNP the buy of the century at slightly over $1 because it is buried in the pink sheets and undiscovered?
Tags: stocks
